Navigation Links
Alliance of Experts Created to Help Raise Awareness of Best Practices in Diabetes Treatment
Date:1/29/2009

Sanofi-aventis U.S. Establishes 'Diabetes National Alliance' of Healthcare Professionals to Help Meet Needs of Growing Diabetes Epidemic in U.S.

BRIDGEWATER, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today the launch of the Diabetes National Alliance to address the growing diabetes epidemic in America and to provide healthcare professionals with information on the standard of care for people living with diabetes. The Diabetes National Alliance is a nationwide initiative designed to raise awareness among primary care professionals about available practices in diabetes treatment and treatment options, including those of sanofi-aventis.

The latest reports from the Centers for Disease Control and Prevention estimate that nearly 24 million Americans have diabetes, including an estimated 5.7 million who remain undiagnosed. Of this number, more than 40 percent of patients with diabetes are not in control of their blood glucose, leaving them at an increased risk of developing long-term diabetes-related complications. With more than 230 million people worldwide currently living with diabetes and this number expected to rise to a staggering 350 million within 20 years, it is imperative that treating healthcare providers are educated and informed about effective diabetes care.

"Most patients with diabetes currently utilize primary care physicians, whose specialty is neither diabetes nor endocrinology," said Dr. Paresh Dandona, director of the Diabetes-Endocrinology Center of WNY at Millard Fillmore Gates Circle Hospital, and Diabetes National Alliance Steering Committee member. "The Diabetes National Alliance provides physicians, diabetes educators and nurses tasked with treating the growing epidemic of diabetes in America with the knowledge and tools aimed at improving patient care."

The Diabetes National Alliance is a national program led by a multidisciplinary
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
2. Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
3. Dr. Patrick Cobb Named President of Community Oncology Alliance
4. Lung Cancer Alliance Hails Early Introduction of Comprehensive Lung Cancer Research Legislation
5. AHCA/Alliance Detail Components of Long Term Care Economic Recovery, Jobs Plan
6. Alliance Techs RFID Technology Enhances Carestream Healths Capability to Connect with Key Prospects at RSNA
7. My1Stop.com Partners with Green Business Alliance to Help Customers Go Green
8. Lung Cancer Alliance Hails Massachusetts State Senator for Taking Lead on Lung Cancer
9. TriServ Alliance Submits Final Bid for TRICARE South Region Contract
10. Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas
11. WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ ...essional cycling team dedicated to ethical sportin...ampions, announced today that it will become Team ...s Optical as a new sponsor of the team. Transition...daptive eyewear, offering the most advanced photoc...
(Date:11/27/2009)... XenaCare Holdings has announced that... Foundation, one of the largest nonprofit organiza...ealth education. , Delray...oldings, Inc. (OTCBB: XCHO), a company specializin...umer healthcare products, has announced today that...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Voyant Health™ announced today... licensed its TraumaCad Enterprise orthopedic temp...solution. , (PRWEB) Novem...ay that Spectrum Health (Grand Rapids, Michigan) h...mplating solution and its TraumaCad Extend workflo...
(Date:11/27/2009)... Specialist manufacturers who use med... saving millions of dollars by bringing in technol...ncreasing numbers of pro-active medical manufactur...e concept stage of their projects, ensuring that p... processes or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...r and sanitation severely limited in Lebanon due t...ncies have stepped up preparations for a coordinat...ess to health care for injured and patients with c...h attacks on July 12. WHO said it is assistin...
...t after memory begins to decline, executive functi...e progression from mild cognitive// impairment, a ...disease. Ron Petersen, M.D., Ph.D., Mayo Cli... "If someone with mild cognitive impairment start...
...ases the risk of hospitalization and death from he... absence of established// risk factors, says a stu... Association. An assistant professor of pre... in early life with hospitalization and subsequent...
... going by the current trends tobacco will probably...e almost 10 times the toll// it took in the 20th c...r of the American Cancer Society said, "In all of ...ncer, 1 in 5 death due to cancer is due to tobacco...
...hout Africa could help to avert about 5,7-million ... that was published in Public Library of Science M... 300 000 deaths and about two million new infectio... circumcision reduces male vulnerability to HIV in...
...ve birth to triplets through IVF procedure three y...ut any infertility treatments. She gave birth to t... because they're healthy and so am I," Magdaleno s...'m happy but, I don't know. I don't know how to ex...
Other Medicine News:Health News:Decline in Concentration, Decision-Making and Problem-Solving 2Health News:Tobacco Epidemic On The Rise 2Health News:Circumcision to Avert HIV Infection 2
(Date:11/27/2009)...Minn, Nov. 27 ACUO TECHNOLOGIES, d...ment software, data migration tools and services, ...nt and Trademark Office has approved a patent appl...a Computer Network." Acuo Technologies is pleased ...ctual property. In general, the granted patent app...
(Date:11/26/2009)...BURG, South Africa, Nov. 26 The 20...e Year Award in the Generic Pharmaceutical Market ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ar Award, the following criteria were used to benc...titors: growth strategy and implementation, degree...
(Date:11/25/2009)...Fla., Nov. 25 American...he Company") is pleased to announce that they have...ment office in Shanghai, China. ,, ASR has been...sential gateway for the development and production...for children and adults to be distributed and sold...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 1American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 3
...entative medicine doctors say they are outraged,ov...rescribing,human growth hormone to treat a hormone...BEACH, Fla., April 27, 2007 /PRNewswire/ -- The ad...enter of a recent New,York Times article about the...dicine (<a target="_blank" href=,"http://worldheal...
...: 0in 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",a...ab-stops: list .5in; mso-list: l1 level1 lfo2">, <...othic MT,; mso-bidi-font-weight: bold">,Independen... adding,Diovan to conventional therapy , , , ,<...in; mso-list: l1 level1 lfo2">, <span style=,"FONT...
Other Medicine Technology:Doctors Outraged Over Growth Hormone Controversy 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
Blue Line® Intubation Stylet 7.5 mm 10 mm
Lighted Pediatric Stylet - Non-Sterile
Surch-Lite™ Flexible Light - 15" Non-Sterile
Peripheral Nerve Stimulator Electrodes
Medicine Products: